Preserving Objectivity in the Clinical Use of PPIs: A Shared Challenge

Preserving Objectivity in the Clinical Use of PPIs: A Shared Challenge For many patients with an acid-related gastrointestinal (GI) disease, a proton pump inhibitor (PPI) is the only reliable pharmacologic option; however, the publication of several observational studies linking PPIs to a variety of potential adverse events (AEs) after extended exposure may be obscuring this conclusion, according to an expert panel that convened recently to assess current evidence and its effect on treating